Transcription profiling of rheumatic diseases
Open Access
- 1 January 2009
- journal article
- review article
- Published by Springer Science and Business Media LLC in Arthritis Research & Therapy
- Vol. 11 (1), 207
- https://doi.org/10.1186/ar2557
Abstract
Rheumatic diseases are a diverse group of disorders. Most of these diseases are heterogeneous in nature and show varying responsiveness to treatment. Because our understanding of the molecular complexity of rheumatic diseases is incomplete and criteria for categorization are limited, we mainly refer to them in terms of group averages. The advent of DNA microarray technology has provided a powerful tool to gain insight into the molecular complexity of these diseases; this technology facilitates open-ended survey to identify comprehensively the genes and biological pathways that are associated with clinically defined conditions. During the past decade, encouraging results have been generated in the molecular description of complex rheumatic diseases, such as rheumatoid arthritis, systemic lupus erythematosus, Sjogren syndrome and systemic sclerosis. Here, we describe developments in genomics research during the past decade that have contributed to our knowledge of pathogenesis, and to the identification of biomarkers for diagnosis, patient stratification and prognostication.This publication has 56 references indexed in Scilit:
- Molecular Subsets in the Gene Expression Signatures of Scleroderma SkinPLOS ONE, 2008
- Molecular discrimination of responders and nonresponders to anti-TNFalpha therapy in rheumatoid arthritis by etanerceptArthritis Research & Therapy, 2008
- Salivary proteomic and genomic biomarkers for primary Sjögren's syndromeArthritis & Rheumatism, 2007
- Blood leukocyte microarrays to diagnose systemic onset juvenile idiopathic arthritis and follow the response to IL-1 blockadeThe Journal of Experimental Medicine, 2007
- Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patientsAnnals Of The Rheumatic Diseases, 2007
- Gene profiling in white blood cells predicts infliximab responsiveness in rheumatoid arthritisArthritis Research & Therapy, 2006
- Cytoskeletal Rearrangements in Synovial Fibroblasts as a Novel Pathophysiological Determinant of Modeled Rheumatoid ArthritisPLoS Genetics, 2005
- A Gene-Expression Signature as a Predictor of Survival in Breast CancerThe New England Journal of Medicine, 2002
- Gene expression profile analysis of rheumatoid synovial fibroblast cultures revealing the overexpression of genes responsible for tumor-like growth of rheumatoid synoviumBiochemical and Biophysical Research Communications, 2002
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingNature, 2000